Director
DIN: 07497477
Sugnesh Dilipbhai Hirpara is currently associated with 3 companies in various capacities such as Director, Individual Promoter and Designated Partner. They serve as a Director at ZEALMAX INNOVATIONS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07497477.Sugnesh Dilipbhai Hirpara is currently involved in 3 different roles. Their most recent position is with CURIFIC CARE PRIVATE LIMITED as a Director. The first company Sugnesh Dilipbhai Hirpara was appointed to as a director was ZEALMAX INNOVATIONS PRIVATE LIMITED. Sugnesh Dilipbhai Hirpara is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Sugnesh Dilipbhai Hirpara is currently associated with 3 companies in various capacities such as Director, Individual Promoter and Designated Partner. They serve as a Director at ZEALMAX INNOVATIONS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 07497477.Sugnesh Dilipbhai Hirpara is currently involved in 3 different roles. Their most recent position is with CURIFIC CARE PRIVATE LIMITED as a Director. The first company Sugnesh Dilipbhai Hirpara was appointed to as a director was ZEALMAX INNOVATIONS PRIVATE LIMITED. Sugnesh Dilipbhai Hirpara is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (2)
Current LLPs (1)
Past Companies (0)
2y 1m 1y 1m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| ZEALMAX INNOVATIONS PRIVATE LIMITED | Director | 01-Jun-2016 |
| ZEALMAX INNOVATIONS PRIVATE LIMITED | Individual Promoter | 01-Jun-2016 |
| CURIFIC CARE PRIVATE LIMITED | Director | 01-Mar-2024 |